UK Clinical Vaccine Network Conference 2023

Bringing together and showcasing the work of the UK clinical vaccine community, to facilitate co-operation and collaborate on future challenges.

Register now

logo as a gif

We are now accepting registrations and sponsor requests for CVNUK 2023, a hybrid event held at the Royal College of Physicians, Liverpool. If you would like to attend, please head to the registrations section and select your package.

Interested in supporting the event? We have a number of sponsorship packages available that can be tailored to your needs. To find out more please contact: Harry Whitworth

If you wish to submit an abstract for consideration at the conference, please contact: Beth Turner. The best poster will receive a £100 cash prize, and a complimentary registration to the following year’s conference.

2022’s Clinical Vaccine Network Conference was held in person at the Royal College of Physicians, London.

Although the conference has now ended, our virtual conferencing platform is still live and hosts recordings for all sessions in addition to downloadable posters. We encourage anyone interested in attending 2023’s conference to register for our On-Demand 2022 conference and view the sessions available.

Keep up to date by connecting with us on twitter: @CVN_UK

Seqirus sponsored the 2022 conference, but has had no input into the arrangements or the content except the session on “Improving Influenza Vaccine Uptake” which has specifically been sponsored and arranged by Seqirus.

To view the recordings from the online UK Clinical Vaccine Network Conference held in 2020 please click here Clinical Vaccines Network Virtual Conference 2020

Dr Susanne Hodgson

Susanne Hodgson is an NIHR Academic Clinical Lecturer in Infection at the University of Oxford. She initially worked with Professor Adrian Hill and Professor Simon Draper at the Jenner Institute on early phase clinical trials of novel vaccines against Plasmodium falciparum and Influenza. This work included controlled human infection (CHIM) studies for each of these conditions. Her DPhil, completed in 2015, involved work at the Jenner Institute and the Kenyan Medical Research Institute in Nairobi and Kilifi to set up the first CHMI for Plasmodium falciparum in Kenya as a means of studing naturally acquired immunity. She is currently working on human monoclonal antibodies targetting VAR2CSA, an important antigen in Plasmodium falciparum infection in pregnancy.

Susanne Hodgson is a Research Fellow and Lecturer in Clinical Medicine at St Peter's College Oxford, coordinator of the Special Study Module for Infectious Diseases at the Unviersity of Oxford Clinical Medicine School and co-lead of the Infection and Immunity Module on the University of Oxford Graduate Entry Medicine Course. She is a physician specialising in Microbiology and Infectious Diseases with a clinical interest in complex surgical infections and is Chief Investigator of the 'Improving Outcomes in Necrotising Otitis Externa (IONOE)' Study (ClinicalTrials.gov Identifier: NCT04950985). She is Trainee Chair of the National Trainee Infection Collaborative for Audit and Research (NITCAR).

Top